Welcome to Oxford Trauma and Emergency Care
Trauma and emergencies are huge issues for patients, the NHS and society more broadly. Oxford Trauma and Emergency Care seeks to improve patient care by designing and testing new treatments and new treatment pathways. We aim to deliver better outcomes for patients and more efficient care within the NHS and other healthcare system worldwide.
We run a number of clinical trials and related studies in trauma and emergency care to guide best practice in the field. Our work informs practice and policy in the NHS and internationally through bodies such as the National Institute for Health and Care Excellence (NICE) guidelines.
Oxford Trauma and Emergency Care is based in the Kadoorie Centre located at the John Radcliffe Hospital, but has collaborations across the University and outside.
Our research focuses on the clinical and cost effectiveness of orthopaedic surgery.
FEBRUARY 2024 TRIAL STATS
Patients recruited
148
New sites
Forth Valley Royal Hospital
St Helier Hospital
St George's Hospital
Royal Berkshire Hospital
Robert Jones and Agnes Hunt Orthopaedic Hospital
Sites with the most recruits in February
Milton Keynes University Hospital with 18
Royal Victoria Hospital, Belfast with 7
Work with us
-
Medical Statistician (171407)
Closing date: 2 April 2024
Botnar Kadoorie Research delivery
An interesting and varied role that includes the development and validation of prediction models, carrying out systematic reviews, cleaning/linking large data sets, and clinical trial development. There is scope for a statistician to specialise within these tasks.
TEAM
RESEARCH
EVENTS
Latest news
The Big BOSS Study Opens to Recruitment!
3 November 2023
Antibiotic bone cement found not to reduce infection after hip replacement
22 June 2023
A large trial has found that using high-dose dual-antibiotic loaded cement is unlikely to reduce the risk of surgical site infection in people who have had a hip replacement.
Kadoorie research paper receives EFORT gold award
19 June 2023
A paper for the PATH-2 trial has received a gold award from the European Federation of National Associations of Orthopaedics and Traumatology (EFORT).